Clinical trial
Combination Chemotherapy With or Without Celecoxib in Treating Patients With…
NCT00064181 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00064181 |
|---|---|
| Title | Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer |
| Official title | Irinotecan Combined With Infusional 5-FU/Folinic Acid or Capecitabine and the Role of Celecoxib in Patients With Metastatic Colorectal Cancer |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | FOLFIRI regimen, capecitabine, celecoxib, fluorouracil, irinotecan hydrochloride, leucovorin calcium |
| Enrollment | 86 |
| Start date | May 1, 2003 |
| Primary completion | Jan 1, 2005 |
| First posted | Jul 9, 2003 |
| Last update posted | Sep 24, 2012 |
| Countries | Belgium, Egypt, Germany, Hungary, Israel |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: